Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Alebund Pharmaceuticals receives FDA clearance for kidney disease trial

Alebund Pharmaceuticals received U S Food and Drug Administration investigational new drug clearance to commence clinical trials for AP308 targeting treatment of IgA nephropathy kidney disease

We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.

Read the original at vir.com.vn →

More in Health & Medicine

More from Thursday 10 September →